NHGRI study highlights role of mitochondria in immune response
A new study highlights how genomic mutations that cause mitochondrial disease may also compromise affected people's immune response.
Last updated: June 8, 2017
Scan to visit
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.
A new study highlights how genomic mutations that cause mitochondrial disease may also compromise affected people's immune response.
Based on clinical data from patients with mitochondrial disease, the researchers created a mouse model of mitochondrial disease in T-cells. T-cells play important roles in human immune response.
The mutations resulted in an increased risk of infection and reduced protective immunity after vaccination, according to Peter McGuire, M.D., senior author and investigator at the National Human Genome Research Institute.
Related Resources
Last updated: June 8, 2017